Celgene Corporation
NDC Database

Celgene Corporation

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 3
  • Latest Marketing Date 2020-03-27
  • Data Source FDA
  • First Marketing Date 2020-03-27
Company Overview

Company

Celgene Corporation

Country

U.S.A

Website

Visit Website

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Celgene Corporation

86 Morris Avenue, Summit, NJ 07901

U.S.A

www.celgene.com/ View on Map
NDC Records ( 3 records )
2020
27 Mar
Drug for Further Processing NDC: 59572-812

Nonproprietary Name

ozanimod hydrochloride

Dosage Form

CAPSULE

Strength

0.23 mg/1

Labeler

Celgene Corporation

Marketing Category

DRUG FOR FURTHER PROCESSING

59572-812

Substance

OZANIMOD HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-03-27

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2020
27 Mar
Drug for Further Processing NDC: 59572-814

Nonproprietary Name

ozanimod hydrochloride

Dosage Form

CAPSULE

Strength

0.46 mg/1

Labeler

Celgene Corporation

Marketing Category

DRUG FOR FURTHER PROCESSING

59572-814

Substance

OZANIMOD HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-03-27

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2020
27 Mar
Drug for Further Processing NDC: 59572-816

Nonproprietary Name

ozanimod hydrochloride

Dosage Form

CAPSULE

Strength

0.92 mg/1

Labeler

Celgene Corporation

Marketing Category

DRUG FOR FURTHER PROCESSING

59572-816

Substance

OZANIMOD HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-03-27

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    25 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    3 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
3 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

59572-812

Nonproprietary Name

ozanimod hydrochloride

Labeler

Celgene Corporation

Dosage Form

CAPSULE

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit